NAAA
BSX icon

New Age Alpha Advisors’s Boston Scientific BSX Stock Holding History

New Age Alpha Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,795
Closed -$113K – 940
2026
Q1 		$113K Buy
1,795
+1,425
+385% +$114K 0.01% 679
2025
Q4 		$35.3K Sell
370
-158
-30% -$15.5K ﹤0.01% 721
2025
Q3 		$51.5K Hold
528
– – ﹤0.01% 755
2025
Q2 		$56.7K Buy
528
+176
+50% +$17.8K ﹤0.01% 768
2025
Q1 		$35.5K Sell
352
-20,571
-98% -$2.07M ﹤0.01% 838
2024
Q4 		$1.87M Buy
20,923
+20,729
+10,685% +$1.82M 0.08% 336
2024
Q3 		$16.3K Buy
+194
New +$15.3K 0.01% 133

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

New Age Alpha Advisors's BSX Position: Q2 2026 in Review

New Age Alpha Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 1,795 shares — an estimated $113K sold.

New Age Alpha Advisors first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $1.87M in Q4 2024. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • New Age Alpha Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • New Age Alpha Advisors sold 1,795 Boston Scientific shares in Q2 2026, an estimated $113K.
  • New Age Alpha Advisors first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • New Age Alpha Advisors's Boston Scientific position peaked at $1.87M in Q4 2024.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.